drugset / Trial / NCT01651598

Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients

NCT01651598

Phase 1 Completed 57 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

In this trial the safety, tolerability, pharmacokinetics and exploratory pharmacodynamics of multiple dose administration of BI 144807 will be investigated in otherwise healthy, controlled asthmatic patients

Timeline

Start
2012-07
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject LAZUCIRNON Small molecule Oral

Indications